Global Autotransfusion Devices Market Expected to Generate a Revenue of $1,939.7 million by 2027, Growing at a CAGR of 6.5% From 2019-2027 - Exclusive Report [190-Pages] by Research Dive

The global autotransfusion devices market is anticipated to witness a tremendous growth during the forecast period, owing to the increasing prevalence of cardiac surgery among people. The hospital sub-segment is expected to be most lucrative. The North America region is expected to dominate in the global industry.

New York,USA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global autotransfusion devices market is expected to generate a revenue of $1,939.7 million by 2027, rapidly growing at a CAGR of 6.5% during the forecast period (2019-2027). The inclusive report provides a brief overview of the current scenario of the market including significant aspects of the market such as growth factors, challenges, restraints, and various opportunities during the forecast period. The report also provides all the market figures making it easier and helpful for the new participants to understand the market.

Download a Exclusive Sample Report Here! @

Dynamics of the Market

Drivers: Rising prevalence of orthopedics and cardiac surgery among people is expected to bolster the growth of the market during the forecast period. In addition, rapid adoption of cardiac device and decreased risk of transfusion devices are further expected to drive the growth of the market in the analysis period.

Restrains: Autotransfusion device does not have the ability to bifurcate the contaminations from blood cells. This factor is expected to impede the growth of the market during the forecast period.

Opportunities: Rising adoption of full body transfusion devices among people is expected to create enormous opportunities for the growth of the global market during the forecast period.

Segments of the Market

The report had divided the market into different segments based on product type, end-user, and region.

Checkout How COVID-19 impacts the Autotransfusion Devices Market. Click Here to Schedule a Call to Speak our Expert Analyst for Triangulate with your own data @

Product Type: Off Pump Transfusion Device Sub-segment to be Most Profitable

The off pump transfusion device sub-segment is expected to grow exponentially at a CAGR of 6.6% during the forecast period. These devices are much safer than the traditional method, and hence, does not cause any blood loss during transfusion. These factors are expected to accelerate the growth of the sub-segment during the forecast period.

End-User: Hospital Sub-segment to be Most Lucrative

The hospital sub-segment is expected to have a noteworthy growth during the forecast period, owing to the pertinence of blood transfusion in various departments to cater appropriate transfusion requirements according to the symptoms. This factor is expected to fuel the growth of the sub-segment during the forecast period.

Region: North America Expected to Dominate the Market

The North America autotransfusion devices market is expected generate a revenue of $884.4 million during the forecast period. Increasing number of hospitals and rising geriatric population in this region are expected to bolster the growth of the market during the forecast period.

Request for Autotransfusion Devices Market Report Customization & Get 10% Discount on this Report@

Key Payers of the Market

The prominent players of the market include

  1. Zimmer Biomet Holding
  2. LivaNova, plc
  3. Stryker Corporation
  4. Teleflex Incorporated
  5. Medtronic Plc
  6. Fresenius Medical Care AG & Co. KGaA
  7. Becton Dickinson and Company
  8. Getinge AB
  9. Haemonetics Corporation
  10. Terumo Corporation

and many more. These players are working on developing strategies such as product development, merger and acquisition, partnerships and collaborations to sustain the market growth.

For instance, in April 2019, Ecomed Solutions, an Illinois-based medical device company, launched a device called HEMAsavR. This is a blood management device that helps doctors collect patient’s lost blood during surgery, and then return it back to their body. This technology significantly eliminates the cost and risk associated with allogeneic blood transfusion.

The report also summarizes many important aspects including financial performance of the key players, SWOT analysis, product portfolio, and latest strategic developments.

In Addition, the report having some numorus point about the leading Business Manufactures, Like, SWOT analysis, Product Portfolio, Finanical Status - Inquire to Get access for Detailed Top Companies Development Strategy Report

Top Trending Reports:

Therapeutic Obstructive Sleep Apnea Devices Market:

Airway Management Devices Market:

Intracranial Pressure Monitoring Devices market:


Contact Data